Back to UHS
BL
Bhushan Lodha
5/28/20260 comments

Explain "One Big Beautiful Bill Act" (OBBBA) impact

Great question — let me build this up from scratch so the mechanics are crystal clear.


Step 1: The Basic Payment Hierarchy

When a hospital treats a patient, how much it gets paid depends entirely on who's paying. There's a well-established pecking order:

PayerTypical Rate
Commercial Insurance100% (the benchmark)
Medicare~87% of commercial
Medicaid (base rate)~60–70% of commercial

Medicaid has always paid the least. The base Medicaid rate is set by each state and has historically been so low that hospitals often lose money on Medicaid patients outright. They've tolerated this because they make it up on commercially insured patients — this is called "cost shifting."


Step 2: What SDPs Were Doing — Closing the Gap

States invented State Directed Payments precisely to fix this problem. The mechanism works like this:

  1. The state tells the private insurer managing its Medicaid program (the "managed care organization" or MCO): "You must pay hospitals at least X rate for Medicaid patients."
  2. That X rate was often set close to — or even at — average commercial rates.
  3. The federal government matches state Medicaid spending, so Washington was effectively co-funding this top-up.

So in practice, a hospital in a state with a generous SDP program wasn't getting paid 60–70 cents on the commercial dollar for Medicaid patients — it was getting paid 90–100 cents. This dramatically changed the economics of treating Medicaid patients.

SDPs grew from just 2 states using them in 2016 to 41 states by 2026, and accounted for more than a quarter of all Medicaid spending in fiscal year 2025. This wasn't a small tweak — it became a massive, structural part of how hospitals got paid. Fierce Healthcare


Step 3: What the Cap Actually Means

Now the OBBBA says: SDPs can't exceed 100% of Medicare rates (in Medicaid expansion states) or 110% of Medicare rates (in non-expansion states).

Here's why this is a big cut. Medicare pays less than commercial insurance — typically around 87 cents for every dollar a commercial insurer pays. So the new ceiling looks like this in concrete terms:

ScenarioWhat hospital gets per $100 of care
Commercial insurer pays$100
Old SDP (at commercial rate)~$95–100
New SDP cap (100% of Medicare)~$87
Old base Medicaid (no SDP)~$60–70

So hospitals in Medicaid expansion states are losing roughly $8–13 per $100 of Medicaid care compared to what they were getting under SDPs. Multiply that across millions of patient visits and it becomes hundreds of millions in lost revenue.

Non-expansion states get a slightly more generous cap at 110% of Medicare (~$96), which is why BofA specifically called out UHS's vulnerability — its geographic concentration in Texas (a non-expansion state) and Florida (an expansion state), which face different but both real pressures. Investing.com


Step 4: House Version vs. Senate Version — Why the Senate Is Much Worse

This is the critical distinction.

The House version said: new SDPs going forward are capped at Medicare rates. But SDPs that were already approved and in place can continue at their current (higher) rates — they're "grandfathered."

So a hospital that already had a generous SDP approved would keep collecting those payments. Only future SDPs would be capped. This is painful but manageable.

The Senate version goes much further. It says: even existing grandfathered SDPs must be reduced 10% per year until they hit the new Medicare-rate ceiling. This is a forced, annual ratcheting down of payments — there's no safe harbor for programs hospitals were counting on.

Here's what that looks like in practice:

Imagine a hospital receiving $100 from an existing SDP (at commercial rate). Under the Senate version:

  • 2026: $100 (still grandfathered)
  • 2027: $90 (10% cut)
  • 2028: $81 (another 10%)
  • 2029: $73...
  • Eventually reaches the Medicare-rate floor (~$87 ceiling, so it stops there)

UHS has estimated that the OBBBA caps will cause it to take in between $420 million to $470 million less in state-directed payments by 2032 — and that estimate was before the Senate's more aggressive phasedown language was introduced. Healthcare Dive


Step 5: Why Non-Expansion vs. Expansion States Matters for UHS

"Medicaid expansion" refers to the ACA's option for states to extend Medicaid eligibility to adults earning up to 138% of the poverty level. 40 states plus DC expanded; 10 states (mostly in the South) did not.

The OBBBA gives non-expansion states a slightly higher SDP ceiling (110% vs. 100% of Medicare) as a partial concession — since those states already have larger uninsured populations and their hospitals absorb more uncompensated care.

UHS has significant exposure in Texas (non-expansion) and Florida (expansion) — two of the largest Medicaid SDP programs in the country. On the Q1 2026 earnings call, UHS's CFO indicated they expect slight declines in Medicaid utilization consistent with expectations, with no major changes in payer mix outside of ACA exchange dynamics — suggesting management is watching Texas closely, where a previously terminated SDP program created additional uncertainty. Investing.com Canada


The Bottom Line

The simplest way to think about it: SDPs were a subsidy that made treating Medicaid patients nearly as financially attractive as treating commercially insured patients. The OBBBA tears down that bridge — not all at once (House version) or gradually over several years (Senate version) — pulling Medicaid reimbursement back toward its historically inadequate base rates. For a company like UHS that runs its entire business model serving a high proportion of Medicaid patients, this isn't a peripheral risk. It strikes at the core economics of roughly half its patient volume.

Source: UHS valuation discount explained

Comments

No comments yet. Readers can leave comments directly from the expanded post on the board page.